Related Experiment Video
Updated: Jun 3, 2026

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy
Thomas Cuny1, Corinne Gerard, Alexandru Saveanu
1Research Center of Neurobiology and Neurophysiology of Marseille, CRN2M, UMR 6231 CNRS, University of Mediterranée, Institut Fédératif Jean Roche, Marseille, France. thomascuny@hotmail.com
Abstract:
In pituitary somatolactotroph cells, G protein-coupled receptors and receptor tyrosine kinases binding their specific ligands trigger an enzymatic cascade that converges to MAP kinase activation in the subcellular compartment. Different signaling pathways, such as AC/cAMP/PKA and PI3K/Akt pathways, interact with MAP kinase to regulate key physiological functions, such as hormonal secretion and cell proliferation. Abnormalities affecting these signaling pathways have been identified as preponderant factors of pituitary tumorigenesis. In addition to trans-sphenoidal surgery, somatostatin analogs are used to control hormonal hypersecretion in GH-secreting adenomas. However, a subset of these tumors remains uncontrolled with these treatFments, calling for new therapeutic approaches. In these cases, novel multivalent somatostatin analogs or new somatostatin-dopamine chimeric molecules could be of interest. Another attractive therapeutic approach may be to use one or several inhibitors acting downstream in the signaling pathway, such as mammalian target of rapamycin inhibitor. Cotargeting therapy and gene therapy are promising tools for these problematic pituitary tumors.
Insights
Pituitary tumors involve signaling pathways like MAP kinase. New therapies targeting these pathways, including somatostatin analogs and mTOR inhibitors, offer hope for difficult-to-treat tumors.
Area of Science:
- Cellular signaling pathways in pituitary biology.
- Endocrinology and neurosurgery.
- Molecular mechanisms of pituitary tumorigenesis.
Background:
- Pituitary somatolactotroph cells utilize signaling cascades, including MAP kinase, AC/cAMP/PKA, and PI3K/Akt pathways.
- These pathways regulate vital functions like hormone secretion and cell proliferation.
- Dysregulation of these signaling pathways is a primary driver of pituitary tumor development.
Purpose of the Study:
- To explore the role of signaling pathways in pituitary tumorigenesis.
- To identify novel therapeutic strategies for refractory GH-secreting adenomas.
- To investigate the potential of downstream signaling inhibitors and combination therapies.
Main Methods:
- Review of signaling cascades in pituitary cells.
- Analysis of current treatments for GH-secreting adenomas.
- Exploration of emerging therapeutic targets and modalities.
Main Results:
- MAP kinase activation is a convergent point for multiple signaling pathways in pituitary cells.
- Existing treatments like somatostatin analogs are insufficient for a subset of tumors.
- Novel therapeutic avenues include multivalent somatostatin analogs, somatostatin-dopamine chimeric molecules, and mTOR inhibitors.
Conclusions:
- Targeting downstream signaling pathways presents a promising therapeutic strategy for problematic pituitary tumors.
- Combination therapies, including cotargeting and gene therapy, show potential for improved treatment outcomes.
- Further research into novel molecular agents is crucial for managing resistant pituitary adenomas.
More Related Videos
09:29Isolation of Targeted Hypothalamic Neurons for Studies of Hormonal, Metabolic, and Electrical Regulation
Published on: August 4, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Secondary Active Transport
Secondary Active Transport
Pharmacogenomics: Identification of New Drug Targets
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signal Transduction: Overview
Typically, signal transduction involves three...